Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
April 16, 2024 16:06 ET
|
Intra-Cellular Therapies Inc.
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization...
New York Mortgage Trust 2024 First Quarter Conference Call Scheduled for Thursday, May 2, 2024
April 16, 2024 16:05 ET
|
New York Mortgage Trust, Inc.
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) is scheduled to report financial results for the three months ended March 31, 2024 after the...
Vespra Hills Golf Club Joins the ClubLink Family of Managed Clubs
April 16, 2024 16:05 ET
|
TWC Enterprises Limited
KING CITY, Ontario, April 16, 2024 (GLOBE NEWSWIRE) -- ClubLink Corporation ULC (subsidiary of TWC Enterprises Limited), Canada’s largest owner, operator and manager of Golf and Country Clubs,...
iLearningEngines, Inc. Becomes Publicly Traded Company After Completing Business Combination With Arrowroot Acquisition Corp., Will Commence Trading on Nasdaq Under Ticker Symbol “AILE”
April 16, 2024 16:05 ET
|
iLearningEngines Holdings, Inc.
BETHESDA, Md. and MARINA DEL REY, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (“iLearningEngines”, “iLE”, or “the Company”), a leader in AI-powered learning automation and...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2024 16:05 ET
|
Annexon Biosciences
BRISBANE, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living...
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
April 16, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
ClearPoint Neuro platform and SmartFlow Cannula to be used by all centers in AviadoBio's ASPIRE-FTD gene therapy trial treating frontotemporal dementia
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
April 16, 2024 16:05 ET
|
Connect Biopharma Holdings Limited
Reported two positive readouts for rademikibart, the Company’s lead asset, from the Global Phase 2b trial in moderate-to-severe persistent asthma and from the China pivotal trial in moderate-to-severe...
SuRo Capital Corp. First Quarter 2024 Preliminary Investment Portfolio Update
April 16, 2024 16:05 ET
|
SuRo Capital Corp.
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today provided the following preliminary update on its...
A-Mark Precious Metals Sets Fiscal Third Quarter 2024 Earnings Call for Tuesday, May 7, at 4:30 p.m. ET
April 16, 2024 16:05 ET
|
A-Mark Precious Metals
EL SEGUNDO, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, will hold a conference call on...
Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
April 16, 2024 16:05 ET
|
Kairous Acquisition Corp. Limited
Singapore, April 16, 2024 (GLOBE NEWSWIRE) -- Kairous Acquisition Corp. Limited (NASDAQ: KACL, the “Company”), a special purpose acquisition company, announced today that Kairous Asia Limited, the...